ESR2 and neoplasm: ER subtypes may also influence disease outcome [52] since activating ERβ may suppress both Cx43 expression and tumor growth [46]; so as posttranslational regulation since Cx43 protein levels were not linked to a prognostic inversion seen at mRNA level in ER negative cases.